Loxo raising $227M in post-ASCO score; Bavarian Nordic reports data delay; Sonar and Stratus ordered to cease production
→ Loxo shared some impressive data at ASCO, and the biotech isn’t about to let that pass without raising more cash. The company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
